99% Savings - Buy Just @1 Rs X
Emildap M Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Emildap M Tablet safe for pregnant women?
Emildap M Tablet has little to no side effects in pregnant women.
Is the use of Emildap M Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Emildap M Tablet. Immediately discontinue Emildap M Tablet if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Emildap M Tablet on the Kidneys?
Emildap M Tablet is completely safe for kidneys.
What is the effect of Emildap M Tablet on the Liver?
Emildap M Tablet does not damage the liver.
What is the effect of Emildap M Tablet on the Heart?
Using Emildap M Tablet does not have any harmful effects on the heart.
Emildap M Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Emildap M Tablet unless your doctor advises you to do so -
Is this Emildap M Tablet habit forming or addictive?
No, you will not get addicted to Emildap M Tablet.
Interaction between Food and Emildap M Tablet
There is no information on the effects of taking Emildap M Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Emildap M Tablet
Consult your doctor before consuming alcohol while taking Emildap M Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826